Spontaneously healed asymptomatic pulmonary tuberculosis: Prevalence of airflow obstruction, and correlation between high-resolution CT findings and pulmonary function tests

Journal of Computer Assisted Tomography

Volumn 36, Issue 5, 2012, Pages 528-533

  Lee, Ki Yeol ^a   Shin, Chol ^b   Lee, Jung Bok ^c   Kang, Eun Young ^a   Oh, Yu Whan ^a   Je, Bo Kyung ^a   Choo, Ji Young ^a   Yoon, Dae Wui ^b   Cho, Pyong Kon ^d  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Catholic University of Daegu   (South Korea)

Author keywords

airway obstruction; computed tomography; prevalence; respiratory function test; tomography; tuberculosis

Indexed keywords

ANTIBIOTICS; COMPUTERIZED TOMOGRAPHY; GLYCOPROTEINS;

AIRWAY OBSTRUCTION; COMPUTED TOMOGRAPHY; FUNCTION TESTS; HIGH-RESOLUTION COMPUTED TOMOGRAPHY; PREVALENCE; PULMONARY FUNCTION TEST; PULMONARY TUBERCULOSIS; RESPIRATORY FUNCTION; RESPIRATORY FUNCTION TEST; TUBERCULOSIS;

INTERFERONS;

GAMMA INTERFERON;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PREVALENCE; PRIORITY JOURNAL; SPONTANEOUSLY HEALED ASYMPTOMATIC PULMONARY TUBERCULOSIS; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

EID: 84866712500     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3182606b8d     Document Type: Article

References (30)

1. Lancaster JF, Tomashefski JF. TuberculosisVa cause of emphysema. Am Rev Respir Dis. 1963;87:435-437.
2. Snider GL, Doctor L, Demas TA, et al. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis. 1971;103:625-640.
3. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55:32-38.
4. Simpson DG, Uschner M, McClement J. Respiratory function in pulmonary tuberculosis. Am Rev Respir Dis. 1963;87:1-16.
5. Plit ML, Anderson R, Van Rensburg CE, et al. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J. 1998;12:351-356.
6. Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med. 1989;83:195-198.
7. Lam KB, Jiang CQ, Jordan RE, et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest. 2010;137:593-600.
8. Joshi R, Patil S, Kalantri S, et al. Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response. PLoS One. 2007;2:e805.
9. Shin C, Lee S, Abbott RD, et al. Relationships between respiratory symptoms and FEV1 in men and women with normal lung function: the Korean health and genome study. Lung. 2005;183:301-309.
10. Helbich TH, Heinz-Peer G, Eichler I, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology. 1999;213:537-544.
11. Song JW, Koh WJ, Lee KS, et al. High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. AJR Am J Roentgenol. 2008;191:1070.
12. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991;179:783-788.
13. de Jong PA, Ottink MD, Robben SG, et al. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology. 2004;231:434-439.
14. Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology. 1996;200:327-331.
15. Bankier AA, De Maertelaer V, Keyzer C, et al. Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology. 1999;211:851-858.
16. Kauczor HU, Hast J, Heussel CP, et al. Focal airtrapping at expiratory high-resolution CT: comparison with pulmonary function tests. Eur Radiol. 2000;10:1539-1546.
17. American Thoracic Society. Standardization of spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107-1136.
18. Morris JF. Spirometry in the evaluation of pulmonary function. West J Med. 1976;125:110-118.
19. Pellegrino R, Brusasco V, Crapo RO, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-968.
20. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991;144:1202-1218.
21. Pasipanodya JG, Miller TL, Vecino M, et al. Pulmonary impairment after tuberculosis. Chest. 2007;131:1817-1824.
22. Kim HY, Song KS, Goo JM, et al. Thoracic sequelae and complications of tuberculosis. Radiographics. 2001;21:839-858.
23. Chakrabarti B, Calverley PM, Davies PD. Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007;2:263-272.
24. Menezes AM, Hallal PC, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30:1180-1185.
25. Habermann TM, Mayo Foundation for Medical Education and Research. Mayo Clinic Internal Medicine Board Review. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
26. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted bythe ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000;161:S221-247.
27. Shukla SJ, Warren DK, Woeltje KF, et al. Factors associated with the treatment of latent tuberculosis infection among health-care workers at a midwestern teaching hospital. Chest. 2002;122:1609-1614.
28. Skjot RL, Oettinger T, Rosenkrands I, et al. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun. 2000;68:214-220.
29. Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999;284:1520-1523.
30. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005;293:2756-2761.